Finally: an understanding of how viruses trigger progressive lung disease in the covid era.
Holtzman Lab is Published in JI Again (Links to an external site)
Finally: an understanding of how viruses trigger progressive lung disease in the covid era.
Patrick Lyons, MD recently submitted an application to the Doris Duke Fund to Retain Clinical Scientists program. Dr. Lyons was chosen to receive a grant for his research project. Through the Doris Duke Fund, Dr. Lyons will receive $25,000 per year and the Pulmonary Division will match the other $25,000. We are excited for Dr. […]
Congrats to Tom Brett, PhD and his lab for getting published in Alzheimer’s and Dementia as a featured article. Check out the paper.
The left photo is PAS-hematoxylin staining of a section of normal lung, and the right is from a section of lung after the development of progressive lung disease long after respiratory viral infection (starting as soon as 5 days and here peaking at 7 weeks after initial infection). In these photos, we are also using […]
Jennifer Alexander-Brett, MD, PhD saved the life of a pregnant mother of 2 from COVID-19. Check out the rest of this inspiring story here.
Adam Anderson, MD has received a grant from BJC. The title of the grant is: Development of a Washington University/Barnes-Jewish Hospital Sarcoidosis Center of Excellence Registry. The award period is from July 1, 2020 to June 30, 2021.
Dr. Michael J. Holtzman received a Technology/Therapeutic Development Award (TTDA) from the Department of Defense for “Preclinical Development of a New Kinase Inhibitor for COPD”. The 3-year award for $3,928,669 will focus on progressive post-viral lung disease, especially relevant to current public health problems with respiratory viral infections including Covid-19, influenza, and other common pathogens. […]
Andrew Michelson, MD, Assistant Professor in Pulmonary and Critical Care Medicine, has received a COVID-19 grant. The project period will be 07/01/20 to 02/28/21. The title of his grant is: “Artificial Intelligence for the Real-time Prediction of Respiratory Deterioration in SARS-COV2 Infected Patients: A Clinical Triage Tool.”
Jennifer Alexander-Brett, MD, PhD has received a R01 from the NHLBI starting July 1, 2020. Her project title is “Non-Classical Cytokine Secretion in Chronic Airway Disease.”
Dr. Patrick Lyons, Instructor of Medicine in The Division of Pulmonary and Critical Care Medicine has been attending in the COVID ICUs and leading the clinical operations on the ground in these units since March 16. The clinical work has involved admitting critically ill patients with diagnosed or suspected COVID-19, performing urgent critical care procedures […]
Dr. Colleen McEvoy, Assistant Professor of Medicine in Pulmonary and Critical Care Medicine has provided extraordinary service to critically ill patients. Dr. McEvoy has been maintaining the scheduling and logistical coordination. She is the co-leader of the COVID Critical Care task force. Since COVID-19 is a new disease, they needed to very quickly provide information […]
Laneshia K. Tague, MD, MSCI has received the American Federation for Medical Research (AFMR) Junior Physician-Investigator Award. This award was created to honor young AFMR investigators whose research projects complement an overall program of research, teaching and clinical medicine. Candidates must have submitted an abstract to one of the AFMR Regional Meetings. Applications were judged […]
Dr. Hrishikesh Kulkarni (Principal Investigator) received a Discovery Award (Peer Reviewed Medical Research Program) from the Department of Defense for the period of 7/1/20 – 6/30/22. Along with Dr. Andrew Gelman (Cardiothoracic Surgery), they will study how activators of the complement cascade (such as pentraxin 3) increase the risk of acute lung injury (primary graft dysfunction) […]
Dr. Kulkarni has received an award from the Children’s Discovery Institute. His grant will be for $300,000 for 5 years. The title is “Harnessing the complement system to mitigate acute lung injury.”
The Lung Transplant Program at Washington University School of Medicine is celebrating its success in completing 103 lung transplants in 2019! Read more.
Michael Hughes, PhD has received an R01 AR075017-01A1 from the NIH. The title is: “A Systematic Analysis of RNA Editing in Skeletal Muscle.” The aims of this study are to determine whether RNA editing influences skeletal muscle specialization using in silico approaches; testing whether muscle-specific trans factors regulate RNA editing by using in vitro cell […]
Dr. Derek Byers was awarded the Bee Award today for going above and beyond for his patients. Congrats to Dr. Byers!
Hrish Kulkarni, MD, MSCI has received a K08 from the NIH. His project title is C3 Mitigates Epithelial Injury in Pneumonia. The project period will be from 09/01/2019 to 08/31/2024.
Andrew Michelson, MD, WU Pulmonary and Critical Care fellow, was recently awarded a travel stipend to attend the June 1 “Un-Meeting: Machine Learning and Artificial Intelligence Applications in Translational Science” by the Center for Leading Innovation and Collaboration (CLIC) at the University of Rochester Medical Center. CLIC, which serves as the coordinating center for the […]
Dr. Laneshia Tague has received a KL2 award with a July 1st, 2019 appointment start. The grant title is “Pharmacogenetic-based Mycophenolate Dosing to Improve Lung Transplant Outcomes”.
Hrishikesh Kulkarni, MD, MSCI, with his collaborating PI, has been awarded a $50,000/one year award for his research project through the SPIRiT funding program. The SPIRiT (Sharing Partnership for Innovative Research in Translation) consortium is a partnership between Clinical and Translational Science Award (CTSA) sites including: Johns Hopkins University, University of Chicago, University of Pennsylvania, University of […]
Congratulations to Dr. Pat Lyons for being awarded an AnnalsATS Editorial Fellowship. Fellows serve 1-3 year appointments and receive mentored guidance in all aspects of manuscript evaluation and publication. More information on ATS Journals.
In March 2019, Steven Brody, MD has received a new R01 from the National Heart, Lung, and Blood Institute. His project title is: “Cellular and Molecular Features of Gene Mutations in Primary Ciliary Dyskinesia.”
Michael J. Holtzman, MD received an Outstanding Investigator Award entitled “Defining and Controlling Airway Disease” from the National Institutes of Health, National Heart, Lung, and Blood Institute. This Project aims at reprogramming epithelial stem cells in the lung to understand and prevent respiratory airway diseases such as asthma and chronic obstructive pulmonary disease (COPD). The award […]